Skip to main navigation Skip to search Skip to main content

What advantage does re-TUR offer in non-muscle invasive bladder cancer, when is it really necessary and can PDD help us with these questions?

  • Graf, S. (Speaker)
  • Eva Sailer (Speaker)
  • Steffen Krause (Speaker)
  • V. Tauber (Speaker)

Activity: Talk or presentationPoster presentationscience-to-science

Period15 Mar 2019
Event titleEAU 2019
Event typeConference
LocationSpainShow on map

Fields of science

  • 302 Clinical Medicine
  • 301 Medical-Theoretical Sciences, Pharmacy
  • 303 Health Sciences
  • 302005 Andrology
  • 304 Medical Biotechnology
  • 305 Other Human Medicine, Health Sciences
  • 302086 Urology